> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comment Period Reopened on Drug Supply Chain
- URL: https://www.fdaweb.com/comment-period-reopened-on-drug-supply-chain/
- Published: 2019-07-08T12:00:00.000Z
- Updated: 2026-09-15T01:36:24.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5144468

*Federal Register* notice: FDA has reopened the comment period for the notices that published in the *Federal Register* of 4/15 and 4/28 regarding issues related to using product identifiers for product tracing, improving the technical capabilities of the supply chain, and identifying system attributes that are necessary to implement the requirements established under the Drug Supply Chain Security Act. The information gathered will allow supply chain stakeholders to share information about relevant piloting activities that are conducted outside of FDA’s Drug Supply Chain Pilot Project Program. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-07-03/pdf/2019-14147.pdf?ref=fdaweb.com).